We consider the optimal design of experimental epidemics modelled as density dependent Markov processes. We focus on finding (i) the optimal times at which to collect data about the state of the system for a small number of discrete observations, (ii) the optimal numbers of susceptible and infective individuals to begin an experiment with, and (iii) the optimal number of replicate epidemics to use. We answer these questions by looking at three commonly widely applied in natural systems, we focus on the use of the models in the context of controlled experimental epidemics or transmission experiments, whose purpose is to inform the practitioner about disease transmission and recovery rates. We adopt the popular D-optimality criterion as providing an appropriate objective function for designing our experiments, since this leads to point estimates with maximum precision. As D-optimal designs for non-linear models are only locally optimal, we also consider the robustness of the designs relative to the misspecification of the model parameters.
and a time-inhomogeneous SI epidemic, and Pagendam and Pollett (2009, the total population size) is reasonably large. We pose the design problem in the classical frequentist framework and illustrate some important findings 66 using time-inhomogeneous SI, time-homogeneous SIS and partially observed 67 SI(k)R (having a gamma distributed infectious period) epidemics as exam-68 ples.
69
In estimating the parameters of epidemic models, our aims are threefold:
70
(i) to find the optimal times to observe the epidemic, (ii) to find the optimal 71 number of infected organisms to introduce to a susceptible population, and
72
(iii) to determine whether there is any difference between running one large 73 experiment or several smaller ones. This is in contrast to previous work 74 that has focussed on optimal observation times alone. Our problem can be is known. This is because k is discrete; the Fisher information is defined 83 for continuous parameters. In the context of experimental epidemics, the 84 choice of k is an issue of model selection, rather than a parameter we wish 85 to estimate. Whilst model selection is beyond the scope of this paper, we 86 note that T -optimal designs and their variants can be used for this purpose, 87 and that the methods and theory presented here is also applicable in that 
where N is the total population size, i is the number of infected individuals, the total time an individual is infectious for has a Gamma(k, β) distribution.
134
We make special note however, that this model is flexible enough to allow as the partially observed SI(k)R (henceforth poSI(k)R) epidemic.
150
The state space S of the SI(k)R epidemic Y t = (S t , I 1,t , . . . , I k,t , R t ) is (k + 2)-dimensional. However, in a closed population we need only account for the number susceptible and the numbers in the infected classes since
For an SI(k)R epidemic the state space can be expressed as 
Diffusion Approximations
Barbour (1972, 1974 
So, they depend on the state y of the process only through the population 166 density y/N , but may depend on t (this is the setup of Barbour (1972) ).
167
Typically, in an experimental epidemic, the index parameter is simply the 168 population ceiling.
169
In the time-inhomogoeneous case, where the transition rates do not de-
170
pend on t, Kurtz (1970) proved a functional law of large numbers for density dependent Markov processes, and this was extended to the present time-
172
inhomogoeneous case by Barbour (1974) : as N → ∞, the density process t /N converges to a unique deterministic trajectory x(t), with x(0) = x 0 and satisfying the system of d first-order ODEs ∂x(t)/∂t =
175
F (x(t); t), where F (x; t) = l lf (x, l; t) (x ∈ E). Convergence is sub-176 ject to certain technical conditions, which are satisfied for many biological 177 models of interest, including all of the epidemic models considered here. See
178
Appendix A for a detailed explanation.
179
Additionally, Kurtz (1971) and Barbour (1974) showed that the fluctu-
180
ations of the density process about the deterministic trajectory, when ap-
181
propriately scaled, converge over finite time intervals to a limiting Gaussian 182 diffusion Z t (see also Pollett (1990 Pollett ( , 2001 ). Let Z expressions for the expectation and cross-covariance of Z t : E(Z t ) = M t z and
where
H(x(u); u) du) (exp(·) denotes the matrix exponential),
188
H(x; t) is the Jacobian matrix of F (x; t), with entries h ij = ∂F j (x; t)/∂x k ,
189
and G(x; t) is the matrix with entries g ij (x; t) = l l i l j f (x, l; t). When the 190 initial condition is fixed as part of the design for an experimental epidemic
191
we will have z = 0.
192
For experimental epidemics these results are very useful for approximating the likelihood of a series of observations. Suppose we make n observations of the density process X ) so that x obs has length nd. Furthermore, let
is the vector value of the limiting deterministic trajectory at t i . The pdf of X obs can be approximated using a multivariate normal distribution:
t , we can approximate the likelihood for a series of observations y from the epidemic using the approximation Y ∼ MVN(N x, N Σ). Here Σ is the cross-covariance matrix having block structure
according to (3).
194
In the case of the (one-dimensional) time-homogeneous (λ = 0) SIS epi-demic,
where x eq = 1 − ρ, is the deterministic trajectory tracked by X as:
It is not always possible to obtain explicit analytical expressions for the en- can be used to find optimal experimental designs in a matter of minutes using 212 a package such as Matlab.
213
For the poSI(k)R epidemic, our inability to observe anything other than
214
I Total at each observation time requires us to make some modifications to
215
Σ and x. We first compute Σ and x as if all dimensions of the process
216
were being observed at each observation. It is then necessary to delete all 217 of the entries from Σ and x that correspond to the unobserved dimensions 218 of the process. Finally, we sum the k elements of x that correspond to the 219 deterministic trajectories of infectious classes and also over the k 2 elements 220 of Σ that correspond to the variances/covariances between infectious classes.
221
This reduces Σ to the n × n covariance matrix of the random variables 
where the dependence of x and Σ on θ has been made explicit. The Fisher information matrix I for our Gaussian process (see Patan and Bogacka (2007)) has entries
which are increasingly dominated by I
(1) i,j as N → ∞.
226

Optimal Design of Experimental Epidemics
227
We assume that, in an experimental epidemic, the practitioner controls: is simply I((x 0 , r, t); θ) = rI((x 0 , 1, t); θ).
246
We aim to find D-optimal experimental designs so that observations of g opt = argmax g∈G det(I(g; θ)).
As mentioned previously, g opt is locally optimal (Chernoff, 1953), since I is 
where p is the dimension of θ.
In some situations, we may only be interested in estimating a subset of 
266
We use a stochastic optimization method known as the Cross-Entropy
267
(CE) method (Rubinstein and Kroese, 2004) for obtaining optimal designs.
268
We generate random designs of the form (X; 
278
For the SIS and SI epidemics, the partial derivatives needed for computing
279
I can be obtained analytically, but the expressions are long, so for brevity we 280 assume that these terms are calculated numerically where required. For the 281 poSI(k)R epidemic, the partial derivatives must be calculated numerically. conditions and observation times) for these three models, assuming r = 1.
288
The three designs considered were: (i) the D-optimal design, (ii) the D- confidence regions computed under these designs are often unreliable.
306
Our optimal designs detailed in Table 2 (including optimal initial condi- at D-optimal designs (n = 3, r = 1) for the SIS epidemic. 
307
Model θ Composition of x 0 SI (β, λ) = (1.0, 0.5) x 0 = i 0 SIS (λ = 0) (β, µ) = (4.0, 1.0) x 0 = i 0 poSI(4)R (β, γ) = (4.0, 4.0) x 0 = (s 0 , i 0 )
Robustness 374
Finally, we consider the robustness of D-optimal designs to misspecifica-375 tion of the parameters for our three models. As mentioned previously, our 376 D-optimal designs require us to have knowledge of the model parameters.
377
Suppose that we guess the parameter θ to be θ guess , so the percentage error is negative compared to when it is positive. This occurs because trajecto- 
Then, the family {Y (N ) t } of Markov processes is said to be density dependent.
423
The process X
, is called the density process. In the time-homogeneous case, where Q does not depend on t, Kurtz Kurtz (1970) proved a functional law, which, as noted by Barbour Barbour (1974), extends to the time-inhomogeneous case. This law stipulates that, for large values of N , the density process 'tracks' a deterministic trajectory x(t) satisfying dx/dt = F (x; t), where
More precisely, we have the following result (whilst more general statements 424 are available, the conditions given here are easy to check, and are satisfied 425 by many biological models of interest, including all of the epidemic models 426 considered in our paper).
427
Theorem 1. Suppose that, for each l = 0, f (x, l; t) is continuous in t,
uniformly in x ∈ E, and that F satisfies the Lipschitz condition |F (x; t) − F (y; t)| < M E |x − y| (x, y ∈ E), for some constant M E . Then, as N → ∞,
t converges uniformly in probability over finite time intervals [0, t] to the unique deterministic trajectory satisfying
That is to say, for fixed t > 0 and for all > 0, 
is bounded and uniformly continuous on E. If with initial value Z 0 = z and characteristic function ψ = ψ(t, θ) satisfying
where h jk (x; t) = ∂F j (x; t)/∂x k .
436
Remark 2. The additional conditions of Theorem 2 will also hold if f (x, l; t) 437 is multinomial.
438
We employ the Cross-Entropy (CE) method of stochastic optimisation Ru- 
, whilst the beta density for the the initial conditions are:
where B(α, β) is the beta function B(α, β) = Γ(α)Γ(β)/Γ(α + β). 
